Mesoblast has an EPS of $-0.105055. In 2022, the company made an earnings per share (EPS) of $-0.133499. Earnings Per Share (EPS) is a financial metric that measures a company's profit allocated to each outstanding share of its common stock. It is calculated by dividing the company's net earnings by the number of outstanding shares.
Year | EPS | Change |
---|---|---|
2023 | -$0.105055 | -21.31% |
2022 | -$0.133499 | -13.78% |
2021 | -$0.154833 | 10.79% |
2020 | -$0.139757 | - |